Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    HHA & AMD-3100

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 332,575Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ayrmid Reports Promising New Real-World Data on Motixafortide
    Ayrmid Reports Promising New Real-World Data on Motixafortide

    06 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-06/ayrmid-reports-promising-new-real-world-data-on-motixafortide-for-stem-cell-mobilization-in-sickle-c

    PHARMIWEB
    06 Dec 2025
    Share Share
    Gland Pharma's Generic Plerixafor Receives Approval in the U.S
    Gland Pharma's Generic Plerixafor Receives Approval in the U.S

    03 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206644

    FDA
    03 May 2024
    Share Share
    Fresenius Kabi Launches Plerixafor Injection
    Fresenius Kabi Launches Plerixafor Injection

    09 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230809432476/en

    BUSINESSWIRE
    09 Aug 2023
    Share Share
    Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. About the subsidiary product Plerixafor Injection Announcement of US FDA approval
    Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. About the subsidiary product Plerixafor Injection Announcement of US FDA approval

    26 Jul 2023

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/nanjing-jianyou-biochemical-pharmaceutical-co-ltd-about-the-subsidiary-product-plerixafor-injection-announcement-of-us-fda-approval-54126.pdf

    PRESS RELEASE
    26 Jul 2023
    Share Share
    Aurobindo Pharma arm gets USFDA nod for Plerixafor injection
    Aurobindo Pharma arm gets USFDA nod for Plerixafor injection

    25 Jul 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-arm-gets-usfda-nod-for-plerixafor-injection/articleshow/102102608.cms

    ECONOMIC TIMES
    25 Jul 2023
    Share Share
    Zydus' Generic Plerixafor Receives Receives Approval in the U.S.
    Zydus' Generic Plerixafor Receives Receives Approval in the U.S.

    11 May 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208980

    FDA
    11 May 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.